Dfp-11207

Catalog No. :
ACPGFB663
CAS No. :
1296177-16-6
Molecular Formula :
C32H26ClFN4O12
Molecular Weight :
713.03

IUPAC Name:4-(((5-chloro-2-((3-(3-(ethoxymethyl)-5-fluoro-2,6-dioxo-1,2,3,6-tetrahydropyrimidine-1-carbonyl)benzoyl)oxy)pyridin-4-yl)oxy)carbonyl)pyridine-2,6-diyl dipropionate

Dfp-11207 structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameDfp-11207
IUPAC Name4-(((5-chloro-2-((3-(3-(ethoxymethyl)-5-fluoro-2,6-dioxo-1,2,3,6-tetrahydropyrimidine-1-carbonyl)benzoyl)oxy)pyridin-4-yl)oxy)carbonyl)pyridine-2,6-diyl dipropionate
Molecular FormulaC32H26ClFN4O12
Molecular Weight713.03
SMILESO=C(C1=CC(OC(CC)=O)=NC(OC(CC)=O)=C1)OC2=CC(OC(C3=CC=CC(C(N(C(N(COCC)C=C4F)=O)C4=O)=O)=C3)=O)=NC=C2Cl
InChI KeyWUQYJRNEHOAADL-UHFFFAOYSA-N
Synonym4-Pyridinecarboxylic acid, 2,6-bis(1-oxopropoxy)-, 5-chloro-2-[[3-[[3-(ethoxymethyl)-5-fluoro-3,6-dihydro-2,6-dioxo-1(2H)-pyrimidinyl]carbonyl]benzoyl]oxy]-4-pyridinyl ester
CAS No.1296177-16-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACPGFB663 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPGFB663 route product structure diagram
    ACPGFB6631296177-16-6
Inquiry

2. ACPGFB663 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPGFB663 route product structure diagram
    ACPGFB6631296177-16-6
Inquiry

Comments (0)